Emil Novruzov

Duesseldorf, NW, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 32 publications

An auxiliary 18F-FDG uptake pattern clarifying equivocal adrenal gland mass after dual-tracer imaging with 123I-mIBG SPECT/CT and 18F-FDG PET/CT.

An auxiliary 18F-FDG uptake pattern clarifying equivocal adrenal gland mass after dual-tracer imaging with 123I-mIBG SPECT/CT and 18F-FDG PET/CT.

Journal: Hellenic journal of nuclear medicine
Published: April 19, 2026

Evaluation of the biodistribution of [99mTc]Tc-PSMA-GCK01 SPECT/CT in a prospective, intraindividual comparison with [68Ga]PSMA-11 PET/CT for phenotyping in mCRPC prior to PSMA-targeted radioligand therapy.

Evaluation of the biodistribution of [99mTc]Tc-PSMA-GCK01 SPECT/CT in a prospective, intraindividual comparison with [68Ga]PSMA-11 PET/CT for phenotyping in mCRPC prior to PSMA-targeted radioligand therapy.

Journal: EJNMMI research
Published: March 25, 2026

Current status of FAP therapy in solid tumors.

Current status of FAP therapy in solid tumors.

Journal: Seminars in nuclear medicine
Published: November 20, 2025

The analysis of biodistribution and tumor uptake of [18F]AlF-FAPI-74 in patients with soft tissue sarcoma and gastro-intestinal tumors compared with [18F]FDG in a prospective, exploratory study.

The analysis of biodistribution and tumor uptake of [18F]AlF-FAPI-74 in patients with soft tissue sarcoma and gastro-intestinal tumors compared with [18F]FDG in a prospective, exploratory study.

Journal: EJNMMI reports
Published: October 23, 2025

Reliability and Practicability of FAP-RADS Version 1.0 for Structured Reporting of FAPI Imaging in Pulmonary and Urothelial Carcinoma.

Reliability and Practicability of FAP-RADS Version 1.0 for Structured Reporting of FAPI Imaging in Pulmonary and Urothelial Carcinoma.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: August 18, 2025

Enhancing reader confidence through dual-time imaging and alternative reconstruction algorithms with [18F]PSMA-1007 PET/CT imaging in local relapsed castration-sensitive prostate cancer?

Enhancing reader confidence through dual-time imaging and alternative reconstruction algorithms with [18F]PSMA-1007 PET/CT imaging in local relapsed castration-sensitive prostate cancer?

Journal: EJNMMI research
Published: August 08, 2025

Predictive Power of Baseline [18F]FDG PET/CT for Adverse Events in DLBCL Patients Undergoing CAR-T Cell Therapy.

Predictive Power of Baseline [18F]FDG PET/CT for Adverse Events in DLBCL Patients Undergoing CAR-T Cell Therapy.

Journal: Diagnostics (Basel, Switzerland)
Published: June 14, 2025

The Clinical Impact of FAPI PET Imaging: HCC, CCC, CUP & Peritoneal Carcinoma.

The Clinical Impact of FAPI PET Imaging: HCC, CCC, CUP & Peritoneal Carcinoma.

Journal: Seminars in nuclear medicine
Published: June 12, 2025

Inter-reader agreement and additive benefit of SPECT or SPECT/CT modality with [99mTc]Tc-pertechnetate scintigraphy imaging for the assessment of thyroid nodules in a tertiary care center.

Inter-reader agreement and additive benefit of SPECT or SPECT/CT modality with [99mTc]Tc-pertechnetate scintigraphy imaging for the assessment of thyroid nodules in a tertiary care center.

Journal: EJNMMI reports
Published: June 02, 2025

Applications of Fibroblast Activation Protein Inhibitor-PET in Interventional Oncology.

Applications of Fibroblast Activation Protein Inhibitor-PET in Interventional Oncology.

Journal: PET clinics
Published: April 29, 2025

Meeting Upcoming Clinical and Diagnostic Needs in Oncologic Imaging: A Structured Reporting System for Fibroblast-Activation-Protein-Targeted Imaging-FAP-RADS Version 1.0.

Meeting Upcoming Clinical and Diagnostic Needs in Oncologic Imaging: A Structured Reporting System for Fibroblast-Activation-Protein-Targeted Imaging-FAP-RADS Version 1.0.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: March 14, 2025

Biphasic contrast-enhanced [18F]PSMA-1007 PET/CT imaging to improve the detection of local relapse of prostate cancer.

Biphasic contrast-enhanced [18F]PSMA-1007 PET/CT imaging to improve the detection of local relapse of prostate cancer.

Journal: EJNMMI research
Published: February 26, 2025
Showing 1-12 of 32

Last Updated: 09/26/2026